DE
ABBV icon

DV Equities’s AbbVie ABBV Stock Holding History

DV Equities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$566K Buy
+2,478
New +$564K 0.1% 63

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

DV Equities's ABBV Position: Q4 2025 in Review

DV Equities opened a new position in AbbVie (ABBV) in Q4 2025: 2,478 shares worth $566K. The stake represents 0.1% of the portfolio and ranks #63 among its holdings.

4,156 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • DV Equities held 2,478 shares of AbbVie worth $566K as of Q4 2025.
  • AbbVie was a new DV Equities position in Q4 2025.
  • AbbVie made up 0.1% of DV Equities's portfolio in Q4 2025, its #63 holding.
  • 4,156 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on DV Equities's 13F filing for Q4 2025, filed 17 Feb 2026.